LARS1 and pancreatic adenocarcinoma: For instance, EPRS1, LARS1, MARS1, TARS2, and YARS2 show increased gene expression in pancreatic adenocarcinoma, clear cell renal cell carcinoma, prostate adenocarcinoma, diffuse large B cell lymphoma, and follicular variant of papillary thyroid carcinoma, respectively9–13.